Effect of ETA/ETB receptor antagonist administration on iNOS gene expression in a rat renal transplantation model.
Herrero
I
I
Department of Medicine, University of Barcelona, Spain.
Torras
J
J
Bover
J
J
Espinosa
L I
LI
Cruzado
J M
JM
Riera
M
M
Hueso
M
M
Lloberas
N
N
Alsina
J
J
Grinyo
J M
JM
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D000077300:Bosentan; D065128:Endothelin Receptor Antagonists; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D007668:Kidney; D016030:Kidney Transplantation / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000235:genetics*; D052247:Nitric Oxide Synthase Type II; D009926:Organ Preservation; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D044022:Receptor, Endothelin A; D044023:Receptor, Endothelin B; D013449:Sulfonamides / Q000494:pharmacology*; D014158:Transcription, Genetic / Q000187:drug effects
D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D012333:RNA, Messenger; D044022:Receptor, Endothelin A; D044023:Receptor, Endothelin B; D013449:Sulfonamides; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496318:Nos2 protein, rat; D000077300:Bosentan